UMB Bank’s Mirum Pharmaceuticals MIRM Stock Holding History

UMB Bank’s Portfolio MIRM Stock Details MIRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$21.5K	Hold	184	–	–	﹤0.01%	1644
2026 Q1	$17K	Hold	184	–	–	﹤0.01%	1658
2025 Q4	$14.5K	Buy	+184	New	+$13.2K	﹤0.01%	1672

Other funds holding MIRM

FLSM

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

Jupiter Topco New York $245B AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UMB Bank's MIRM Position: Q2 2026 in Review

UMB Bank held its Mirum Pharmaceuticals (MIRM) position steady in Q2 2026 at 184 shares worth $21.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1644.

UMB Bank first reported a position in MIRM in Q4 2025 and has held it in 3 quarters since. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

UMB Bank held 184 shares of Mirum Pharmaceuticals worth $21.5K as of Q2 2026.
UMB Bank left its Mirum Pharmaceuticals share count unchanged in Q2 2026.
Mirum Pharmaceuticals made up ﹤0.01% of UMB Bank's portfolio in Q2 2026, its #1644 holding.
UMB Bank first reported a position in Mirum Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on UMB Bank's 13F filing for Q2 2026, filed 13 Aug 2026.